MIRA INFORM REPORT

 

 

Report Date :

05.11.2014

 

IDENTIFICATION DETAILS

 

Name :

SQUARE PHARMACEUTICALS LTD.

 

 

Registered Office :

Square Centre 48, Mohakhali C/A, Dhaka-1212

 

 

Country :

Bangladesh

 

 

Financials (as on) :

31.03.2013

 

 

Date of Incorporation :

10.11.1964

 

 

Legal Form :

Public Listed Co    

 

 

Line of Business :

Manufacturer, Exporter, Distributor of Pharmaceutical Finished Products, Basic Chemicals, AgroVet Products Pesticide Products, Small Volume Parental Opthalmic Products and Insulin Products.

 

 

No. of Employees :

5868

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Aa

 

RATING

STATUS

PROPOSED CREDIT LINE

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

Large

 

Status :

Good

Payment Behaviour :

Regular 

Litigation :

Clear

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – June 1, 2014

 

Country Name

Previous Rating

(31.03.2014)

Current Rating

(01.06.2014)

Bangladesh

B1

B1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

BANGLADESH - ECONOMIC OVERVIEW

 

Bangladesh's economy has grown roughly 6% per year since 1996 despite political instability, poor infrastructure, corruption, insufficient power supplies, slow implementation of economic reforms, and the 2008-09 global financial crisis and recession. Although more than half of GDP is generated through the service sector, almost half of Bangladeshis are employed in the agriculture sector with rice as the single-most-important product. Garment exports, the backbone of Bangladesh’s industrial sector and 80% of total exports, surpassed $21 billion last year, 18% of GDP. The sector has remained resilient in recent years amidst a series of factory accidents that have killed over 1,000 workers and crippling strikes that shut down virtually all economic activity. Steady garment export growth combined with remittances from overseas Bangladeshis, which totaled almost $15 billion and 13% of GDP IN 2013, are the largest contributors to Bangladesh’s current account surplus and record foreign exchange holdings.

 

Source : CIA

 


 EXECUTIVE SUMMARY

 

IDENTIFICATION DETAILS

 

Correct company Name

:

Square Pharmaceuticals Ltd.

Head Office

:

Square Centre 48, Mohakhali C/A, Dhaka-1212, Bangladesh.

Tel No

:

88-02-8833047-56, 9859007 (10 lines)

Fax No

:

88-02-8834941, 8828768, 8828609, 831328403

E-mail

:

info@squaregroup.com

afsar@squaregroup.com

gmostafa@squaregroup.com

Website

:

www.squarepharma.com.bd

Date/ Year of Incorporation

:

10.11.1964

Incorporation No.

:

C-2252  

Legal Form (General)

:

 Public Listed Co      Public (but not listed)   Private Co   State-owned Co

 Sole Proprietorships  Partnership            Not Registered

 others (please specify) ________________

Legal form (Specific)

:

LTD   CORP    INC  CO    

 others (please specify) ________________

Issuing Authority

:

Registrar of Joint Stock Companies & Firms   City Corporation

 Municipal Administration                               Union Council

 Cantonment Board                                         Chief Controller of  Import & Export (CCIE)

 

 

FINANCIALS- SUMMARY

      Year

Turnover/ Sales

 Assets

     Income

31st March’2012

Tk. 18,592,856,236

Tk. 21,453,784,762

Tk. 3,037,696,965

31st March’2013

Tk. 20,742,746,372

Tk. 23,447,645,506

Tk. 3,239,948,829

Exchange Rate

USD1-Tk. 77.8200

EUR 1- Tk. 100.2711

GBP 1- Tk.118.5354

AUD 1 - Tk.82.8563

JPY 1 - Tk.0.9286

CAD 1 - Tk.80.1887

SEK 1 - Tk.12.2870

SGD 1 - Tk.65.3045

CNH 1 - Tk.12.8399

 

 

 

 

 

 

FULLCHECK REPORT DETAILS

 

                                    Information Parted By

 

 

 

Name

:

Mr. Khandakar Habibuzzaman

Designation

:

Company Secretary

Contract No

:

N/A

 

                                     Locations Details

 

Business Address

:

Square Centre 48, Mohakhali C/A, Dhaka-1212, Bangladesh.

Tel No

:

88-02-8833047-56, 9859007 (10 lines)

Fax No

:

88-02-8834941, 8828768, 8828609, 831328403

E-mail

:

info@squaregroup.com

afsar@squaregroup.com

gmostafa@squaregroup.com

Website

:

www.squarepharma.com.bd

 

Location :

: Owned

Ö

 

Rented

 

 

Leased

 

Area

8500

Sq. ft.

 

Type of Office :

  :       Commercial Office Bldg.

Ö

 

Semi-commercial office Bldg.

 

     

Retail shop

 

 

Industrial Park

 

     

Business Center

 

 

Home Office

 

     

Residential Bldg.

 

 

 

 

 

 

Factory:

 

 

 

 

 

Address

:

(1) Square Road, Salgaria, Pabna, Bangladesh.

(2) Board Ghar Bazar Kaliakoir, Gazipur, Bangladesh.

Tel No

:

N/A

Fax No

:

N/A

 

Location :

   Owned

Ö

 

Rented

 

 

Leased

 

Area

4.5

Acres

 

Branches:

 

 

 

 

 

Address

:

N/A

Tel No

:

N/A

Fax No

:

N/A

 

Employee:

 

 

 

No. of Employees 

 

Executive

:

2829

Worker

:

1288

Non-executive

:

1751

Total

:

5868

Details:

 

                     

 

 

 

OWNERSHIP/SHAREHOLDERS

 

Names of Shareholders

                                 No. of Share     

Mr. Samuel S Chowdhury

26,187,385

Mrs. Ratna Patra

25,098,213

Mr. Tapan Chowdhury

26,757,549

Dr. Kazi Harunar Rashid

11,384,856

Mr. Anjan Chowdhury

27,096,349

Mr. Kazi Iqbal Harun

11,209,618

Mr. Md. Kabir Reza

4,709

Mr. Md. Majibur Rahman Bhuiyan

6,360

Mr. Anjan Kumar Paul

62,202

Mr. Muhammadul Haque

22,274

Mr. Mahbubur Rahman

3,710

Sponsors

73173693

Foreign Investors

35,785,497

Financial and Other Institutions

100,778,061

General Public

33,198,188

 

DIRECTORS

 

Name

Designation

Mr. Samuel S. Chowdhury

Chairman

Mrs. Ratna Patra

Vice Chairman

Mr. Tapan Chowdhury

Managing Director

Dr. Kazi Harunar Rashid

Director

Mr. Anjan Chowdhury

Director

Mr. Kazi Iqbal Harun

Director

Mr. M. Sekander Ali

Independent Director

Mrs. Nihad Kabir

Independent Director

 

 

MANAGEMENT

 

Name

:

Mr. Parvez Hashim

Job Description

:

Head of Operations

Nationality

:

Bangladeshi

Email address

:

N/A

Other details

:

N/A

 

 

 

Name

:

Mr. M Ashiqul Hoque Chawdhury

Job Description

:

Head of Admin & Supply Chain

Nationality

:

Bangladeshi

Email address

:

N/A

Other details

:

N/A

 

 

 

Name

:

Mr. Khandaker Habibuzzaman

Job Description

:

Company Secretary

Nationality

:

Bangladeshi

Email address

:

N/A

Other details

:

N/A

 

BUSINESS OPERATIONS

 

Nature of Activity       :

Manufacturer

Ö

Trader

 

Dealer

 

Distributor

Ö

 

 

 

Exporter

Ö

Importer

 

Services

 

Others

 

 

Range of Products:

 

Products

:

Pharmaceutical Finished Products, Basic Chemicals, AgroVet Products Pesticide Products, Small Volume Parental Opthalmic Products and Insulin Products.

Production Capacity

:

N/A

Last Year Production

:

N/A

 

Trading Terms:

 

Purchasing Terms:

L/C

Ö

Cash

 

Others

 

 

 

Credit :

 

30 days

 

60 days

Ö

90 days

 

 

days

 

Selling Terms      :

L/C

 

Cash

Ö

Others

 

 

 

Credit :

Ö

30 days

 

60 days

 

90 days

 

 

days

DETAILED DATA

 

Trade Reference & Related Parties

:

 

Overseas Clients

:

N/A

Local Clients

:

Local Pharmacy

Overseas Suppliers

:

N/A

Local Suppliers

:

N/A

 

Trade Markets

 

:

 

Exports

 

:

Sri lanka, India, Bhutan, Vietnam.

 

Imports

 

:

China, India, Germany, Singapore, UK

Brand Name

:

Square

Certified

:

Nil

Auditors

:

M/s. Das Chowdhury Dutta & Co.

Chartered Accountants

Well Tower, 1st Floor, Flat-A/1

12/A Purana Paltan Line, Dhaka

Operation Status

:

Active

Member

:

Dhaka Chamber of Commerce & Industry

 

 

CAPITAL STRUCTURE

 

Authorized Capital

:

Tk. 5,000 million

Paid-up Capital

:

Tk.3,707,686,640

No. of Shares

:

370,768,664

 Share Value

:

Tk.10.00Each

Main Assets

:

Tk. 23,447,645,506

 

 

 

 

 

FINANCIAL STATEMENT- DETAILED

 

Balance Sheet :

 

  Currency

: Tk.

 

       Denomination

: 1

 

         Financial Year Ending

: 31st March’2013


 

Income Statement :

 

  Currency

: Tk.

 

       Denomination

: 1

 

         Financial Year Ending

: 31st March’2013


ASSOCIARES/SUBSIDIARIES/ RELATED PARTIES

 

Associate Company

:

Square Textiles Ltd.

­Square Knit Fabrics Ltd.

­Square Fashions Ltd.

Square Hospitals Ltd.

Subsidiary

:

Square Cephalosporins Ltd.

Square Formulations Ltd.

Name of  The Group

:

Square Group

 

 

BANKING

 

Bank Name  

:

Janata Bank Ltd.

Citibank N.A

Standard Chartered Bank

HSBC Ltd.

Commercial Bank of Ceylon Ltd.

Eastern Bank Ltd.

Prime Bank Ltd.

Bank Alfalah Ltd.

Shahjalal Islami Bank Ltd.

Trust Bank Ltd.

Bank Asia Ltd.

 

 

ADVERSE DATA MONITORING

 

Dishonored Checks           

 

:     

No Record Found         

Debt

 

:

No Record Found

Litigation  

                   

:

Clear          

Performance Defaults

 

:

No Record Found         

Adverse Local Media Coverage/ Adverse Filling History

:

No Record Found

 

 


SITE VISIT COMMENTARY

 

Our representative visited the subject company Head address which is situated at 48, Mohakhali C/A, Dhaka-121, Bangladesh. The subject Company Secretary Mr. Khandakar Habibuzzaman gave us all information. Is situated at commercial area which is a well decorated modern office.

 

 

GENERAL COMMENTS

 

Subject is mainly engaged in Manufacturer, Exporter & Distributor of Readymade Garments. The subject company maintains acceptable business volume.

Based on the financial statements, SC’s financial performance appears to be Strong. Having been in operation for several years, Subject enjoys some recognition and impact in the line.

 

 

 


 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.61.41

UK Pound

1

Rs.98.06

Euro

1

Rs.76.67

 

 

INFORMATION DETAILS

 

Report Prepared by :

TPT

 

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.